Literature DB >> 19135131

The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model.

Yan-Ting Gu1, Li-Juan Qin, Xin Qin, Feng Xu.   

Abstract

This study was performed to determine whether dexamethasone (DEX) had an effect on calcium-activated potassium channels (K(Ca) channels) and Occludin protein in blood-brain tumor barrier (BTB). Using a rat brain glioma model, we found that the expression of K(Ca) channels protein and Occludin protein was significantly increased in brain tumor tissue after DEX treatment for 3 days. Compared with non-DEX-treated animals, Evans Blue levels were greatly attenuated in DEX-treated animals. These effects were significantly reversed by the glucocorticoid receptor antagonist RU38486. In addition, DEX treatment enhanced the density of I(KCa) in the rat brain microvascular endothelial cells (RBMECs) in vitro BTB. All of these results strongly suggest that DEX could be involved in the regulation of both transcellular and paracellular pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135131     DOI: 10.1016/j.neulet.2008.12.047

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation.

Authors:  Colleen S Curran; Michael D Evans; Paul J Bertics
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

2.  Functional coupling of TRPV4, IK, and SK channels contributes to Ca(2+)-dependent endothelial injury in rodent lung.

Authors:  Mike T Lin; Ming-Yuan Jian; Mark S Taylor; Donna L Cioffi; Fui C Yap; Wolfgang Liedtke; Mary I Townsley
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

Review 3.  Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms.

Authors:  Roger Murayi; Prashant Chittiboina
Journal:  Childs Nerv Syst       Date:  2016-09-09       Impact factor: 1.475

Review 4.  Eosinophils in glioblastoma biology.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Neuroinflammation       Date:  2012-01-17       Impact factor: 8.322

Review 5.  Gliomas and the vascular fragility of the blood brain barrier.

Authors:  Luiz Gustavo Dubois; Loraine Campanati; Cassia Righy; Isabella D'Andrea-Meira; Tania Cristina Leite de Sampaio E Spohr; Isabel Porto-Carreiro; Claudia Maria Pereira; Joana Balça-Silva; Suzana Assad Kahn; Marcos F DosSantos; Marcela de Almeida Rabello Oliveira; Adriana Ximenes-da-Silva; Maria Celeste Lopes; Eduardo Faveret; Emerson Leandro Gasparetto; Vivaldo Moura-Neto
Journal:  Front Cell Neurosci       Date:  2014-12-12       Impact factor: 5.505

6.  Re-exposure to the hypobaric hypoxic brain injury of high altitude: plasma S100B levels and the possible effect of acclimatisation on blood-brain barrier dysfunction.

Authors:  C D Winter; T Whyte; J Cardinal; R Kenny; E Ballard
Journal:  Neurol Sci       Date:  2016-02-29       Impact factor: 3.307

7.  The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144.

Authors:  Heng Cai; Yixue Xue; Ping Wang; Zhenhua Wang; Zhen Li; Yi Hu; Zhiqing Li; Xiuli Shang; Yunhui Liu
Journal:  Oncotarget       Date:  2015-08-14

8.  PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis.

Authors:  Shuyuan Shen; Hai Yu; Xiaobai Liu; Yunhui Liu; Jian Zheng; Ping Wang; Wei Gong; Jiajia Chen; Lini Zhao; Yixue Xue
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-30       Impact factor: 8.886

Review 9.  Emerging insights into barriers to effective brain tumor therapeutics.

Authors:  Graeme F Woodworth; Gavin P Dunn; Elizabeth A Nance; Justin Hanes; Henry Brem
Journal:  Front Oncol       Date:  2014-07-21       Impact factor: 6.244

10.  The role of histamine in opening blood-tumor barrier.

Authors:  Zeng Wang; Xin-Jun Cai; Jing Qin; Fa-Jun Xie; Na Han; Hong-Yang Lu
Journal:  Oncotarget       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.